Michael O Sullivan - 23 Jun 2022 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
Chief Financial Officer
Signature
/s/ Mark A. Catchur, as Attorney-in-Fact for Michael O. Sullivan
Issuer symbol
OGEN
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
4
Filing time
24 Jun 2022, 16:15:28 UTC
Previous filing
30 Mar 2022
Next filing
02 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGEN Employee Stock Option (Right to Buy) Award $0 +250,000 $0.000000 250,000 23 Jun 2022 Common Stock 250,000 $0.2950 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, in connection with interim service to the Company as Principal Executive Officer. The option vests immediately. The option exercise price is the closing price on the date of the grant, June 23, 2022.